4,4- BISMALEIMIDO-3,35,5 -TETRAMETHYLDIPHENYLMETHANE(DMX/BMI) (105357-11-7)

Other Product

• 4,4- BISMALEIMIDO-3,3-DIMETHYLDIPHENYLMETHANE(DMT/BMI)
• 4-Dimethylamino-35-dinitrobenzoicacid
• 38660-35-4
• 121281-35-4
• 3,6,9,12,15,18,21,24,27,30,33-Undecaoxapentatriacontan-1-ol,35-(4-nonylphenoxy)-
• Technetate(1-)-99Tc,[[1,1'-[[1-[[[3-(dimethylamino)propyl]methylamino]methyl]-1,2-ethanediyl]di(imino-kN)]bis[2-methyl-2-propanethiolato-kS]](4-)]oxo-, hydrogen, (SP-5-35)-(9CI)
• Technetium-99Tc,[1-[[2-[[2-(4-iodophenyl)ethyl](2-mercapto-2-methylpropyl)amino]-1,1-dimethylethyl]amino]-2-methyl-2-propanethiolato(3-)-N,N',S,S']oxo-,(SP-5-35)- (9CI)
• BMI-X
• BMI-DOPA
• BCO 35/5
• 422565-35-3
• Acrylonitrile-13C3 (stabilized with 35-45 ppM 4-hydroxy anisole)
• Guanidine,N-[5-(35-butyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxooxacyclohexatriaconta-4,20-dien-2-yl)-4-hydroxyhexyl]-
• Guanidine,N-[5-(35-butyl-10,12,14,16,18,19,22,26,30,34-decahydroxy-3,5,21,33-tetramethyl-36-oxooxacyclohexatriaconta-4,20-dien-2-yl)-4-hydroxyhexyl]-
• Guanidine,[4-hydroxy-5-[10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyloxacyclohexatriaconta-4,20-dien-2-yl]hexyl]-(9CI)
• Guanidine,[5-[35-hexyl-10,12,14,16,18,19,22,26,30,34-decahydroxy-3,5,21,33-tetramethyl-36-oxooxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]-(9CI)
• Guanidine, [5-[19-(a-D-arabinofuranosyloxy)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyloxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]-(9CI)
• Guanidine,[5-[10,12,14,16,18,19,22,26,30,34-decahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyloxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]-(9CI)
• Guanidine, [5-[19-(a-D-arabinofuranosyloxy)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxooxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]-(9CI)
• Guanidine,[5-[35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxooxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]-(9CI)